Tumor targeting in cancer therapy /
| Other Authors: | |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Totowa, N.J. :
Humana Press,
[2002]
|
| Series: | Cancer drug discovery and development.
|
| Subjects: |
Table of Contents:
- The current status of tumor targeting : a review
- Clinical applications of targeted therapeutics
- Targeting the CD22 receptor with RNA damaging agents
- The development of liposomes for enhanced delivery of chemotherapeutics to tumors
- Overcoming multiple drug resistance with anti-pgp carrier
- Targeting with transferrin
- Synthesis and evaluation of paclitaxel immunoconjugate with antitumor activity in vitro
- The use of drug-monoclonal antibody conjugates for the treatment of cancer
- Targeting vascular endothelium with antibodies
- Targeting B-cell non-Hodgkin's lymphoma with monoclonal antibodies
- From bench to bedside : development of Rituximab (Rituxan®), a monoclonal antibody for the therapy of non-Hodgkin's lymphoma
- Mylotarg : the first antibody-targeted chemotherapy agent
- ¹⁸⁸Rhenium-labeled trisuccin-deltaCh2HuCC49 as a radioimmunotherapy model in nude mice
- General approach for targeting toxins
- Antibody-toxin conjugates : chemistry of coupling and purification
- Shiga-like toxins as targeted anticancer agents 00 Antibody-directed enzyme prodrug therapy with carboxypeptidase G2 : clinical studies
- Photodynamic therapy : targeting cancer cells with photosensitizer-bioconjugates
- Tumor targeting using PEG-m_THPC for photodynamic therapy in a rat ovarian-cancer model
- Targeting tumors with magnetic drugs
- Internalization of antibodies
- Bioconjugation and biodistribution
- Principles of antitumor targeting of cytotoxic drugs
- Targeting by antibody or ligand : which is better?